BackCore Scientific- Warrants Tranche 1 (23/01/2027) Overview

Core Scientific- Warrants Tranche 1 (23/01/2027) Profit Margin

Latest profit margin for Core Scientific- Warrants Tranche 1 (23/01/2027): -18.62% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

505.93%
↑ 379.78% YoY

As of Sep 2026

Annual Profit Margin (TTM)

-18.62%
↑ 91.90% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Core Scientific- Warrants Tranche 1 (23/01/2027) (CORZW) FAQ

Core Scientific- Warrants Tranche 1 (23/01/2027) posts a profit margin of -18.62% as of September 2026. That compares with -229.91% in the prior-year period — up 91.9% year over year. That is below the Technology sector average of 22.47%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Core Scientific- Warrants Tranche 1 (23/01/2027)'s profit margin was -229.91%. The latest reading is -18.62% — a 91.9% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Technology stocks, a profit margin near 22.47% is typical. Core Scientific- Warrants Tranche 1 (23/01/2027)'s -18.62% is lower that level. That is roughly 182.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Core Scientific- Warrants Tranche 1 (23/01/2027)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -18.62% as of September 2026; use YoY and peer views to separate noise from signal.

Context for CORZW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 22.47%), and (3) consistency with growth and profitability. This page covers the first two; Core Scientific- Warrants Tranche 1 (23/01/2027)'s other metric pages and overview cover the third.